sec filing

AMEX · PLX
Protalix BioTherapeutics, Inc. Common Stock
Healthcare · Biotechnology
$2.71
Up+$0.02 (+0.74%)
Updated Oct 6, 2026, 11:52 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 146.37M
- P/E ratio
- 26.75
- Dividend yield
- 0.00%
- 52-week range
- $1.88 – $2.98
- Volume
- 984.06K
- Avg. volume
- 789.76K
Price performance · PLX
PLX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
PLX closed at $2.71 after 20 trading sessions, up 2.26% for the selected period.
- Last close
- $2.71
- Period change
- +2.26%
- Period low
- $2.64
- Period high
- $2.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $2.68 | $2.74 | $2.65 | $2.71 | 984.06K |
| Oct 2, 2026 | $2.70 | $2.72 | $2.64 | $2.71 | 947.41K |
| Oct 1, 2026 | $2.77 | $2.77 | $2.60 | $2.68 | 1.59M |
| Sep 30, 2026 | $2.69 | $2.815 | $2.68 | $2.76 | 836.26K |
| Sep 29, 2026 | $2.69 | $2.735 | $2.6803 | $2.69 | 898.56K |
| Sep 28, 2026 | $2.71 | $2.72 | $2.61 | $2.69 | 832.82K |
| Sep 25, 2026 | $2.76 | $2.775 | $2.70 | $2.72 | 386.03K |
| Sep 24, 2026 | $2.78 | $2.8167 | $2.73 | $2.75 | 302.7K |
| Sep 23, 2026 | $2.84 | $2.8495 | $2.765 | $2.80 | 586.41K |
| Sep 22, 2026 | $2.75 | $2.84 | $2.75 | $2.84 | 854.9K |
| Sep 21, 2026 | $2.71 | $2.78 | $2.69 | $2.75 | 471.38K |
| Sep 18, 2026 | $2.68 | $2.715 | $2.66 | $2.69 | 1.25M |
| Sep 17, 2026 | $2.71 | $2.725 | $2.68 | $2.70 | 321.89K |
| Sep 16, 2026 | $2.68 | $2.705 | $2.62 | $2.68 | 1.06M |
| Sep 15, 2026 | $2.75 | $2.75 | $2.64 | $2.66 | 812.74K |
| Sep 14, 2026 | $2.63 | $2.79 | $2.6201 | $2.77 | 952.16K |
| Sep 11, 2026 | $2.74 | $2.75 | $2.615 | $2.64 | 646.81K |
| Sep 10, 2026 | $2.66 | $2.735 | $2.64 | $2.73 | 782.52K |
| Sep 9, 2026 | $2.68 | $2.68 | $2.595 | $2.67 | 580K |
| Sep 8, 2026 | $2.66 | $2.67 | $2.60 | $2.65 | 908.36K |
Latest PLX news
The latest Smart Investors Daily articles mentioning PLX.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

